Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
RETRACTED: Waheed et al. Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A. Molecules 2019, 24, 3722.
Journal: Molecules (Basel, Switzerland)
Published: October 24, 2025
Superior Survival Outcomes of Epithelial Ovarian Cancer Patients in the Universal Access Military Healthcare System Compared With the National Surveillance, Epidemiology, and End Results Program.
Journal: Military medicine
Published: April 21, 2025
RETRACTED: Paucarmayta et al. Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro. Biomedicines 2020, 8, 73.
Journal: Biomedicines
Published: March 12, 2025
Pegylated liposomal doxorubicin does not affect cardiac function in patients treated for gynecologic malignancies.
Journal: Gynecologic oncology reports
Published: January 17, 2025
Retraction Note: Progesterone induces apoptosis by activation of caspase-8 and calcitriol via activation of caspase-9 pathways in ovarian and endometrial cancer cells in vitro.
Journal: Apoptosis : an international journal on programmed cell death
Published: December 31, 2024
Live birth after uterine-sparing treatment of pyometra following abdominal myomectomy: A case report.
Journal: Case reports in women's health
Published: October 14, 2024
Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States.
Journal: Cancers
Published: February 08, 2024
Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
Journal: Gynecologic oncology
Published: October 27, 2023
Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes.
Journal: Gynecologic oncology
Published: October 23, 2023
Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 17, 2023
The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study.
Journal: Gynecologic oncology
Published: July 29, 2022
Last Updated: 09/26/2026